RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$696M
AUM Growth
+$65M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$13.8M
3
+$10.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.96M
5
SNY icon
Sanofi
SNY
+$7.67M

Top Sells

1
+$11.2M
2
+$10.8M
3
+$8.62M
4
ESPR icon
Esperion Therapeutics
ESPR
+$8.33M
5
BIIB icon
Biogen
BIIB
+$5.29M

Sector Composition

1 Healthcare 92.59%
2 Financials 0.93%
3 Technology 0.13%
4 Energy 0.1%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$310K 0.04%
2,806
102
$296K 0.04%
5,368
103
$272K 0.04%
1,847
104
$187K 0.03%
23,400
105
$183K 0.03%
50,000
106
$79K 0.01%
1,221
107
$61K 0.01%
23,920
108
$41K 0.01%
25,000
109
– –
-5,125
110
– –
-36,000
111
– –
-90,000
112
– –
-5,000
1 2 3 4
5